نتائج البحث

Disease-modifying antirheumatic drugs and risk of thyroxine-treated autoimmune thyroid disease in patients with rheumatoid arthritis

• Authors : Waldenlind, K; Delcoigne, B; Saevarsdottir, S

Subjects: Medicin och hälsovetenskap

• Source: Journal of internal medicine. 295(3):313-321

تفاصيل العنوان

Effectiveness of JAK Inhibitors Compared With Biologic Disease-Modifying Antirheumatic Drugs on Pain Reduction in Rheumatoid Arthritis: Results From a Nationwide Swedish Cohort Study

• Authors : Eberhard, Anna; Di Giuseppe, Daniela; Askling, Johan

• Source: Arthritis & Rheumatology. 77(3):253-262

تفاصيل العنوان

Comparison of the Efficacy and Safety of Disease‐Modifying Antirheumatic Drugs Combination Therapies: A Systematic Review and Network Meta‐Analysis.

• Authors : Liu, Linfeng^1,2 (AUTHOR); Ambe, Kaori¹ (AUTHOR); Onishi, Mayu¹ (AUTHOR)

• Source: CTS: Clinical & Translational Science. Mar2025, Vol. 18 Issue 3, p1-11. 11p.

تفاصيل العنوان

Complications of invasive oral procedures in patients with immune-mediated inflammatory disorders treated with biological and conventional disease-modifying antirheumatic drugs or glucocorticoids: a scoping review of the literature

• Authors : Loredana Radoi; Mohamed Kadri; Marjolaine Gosset

Subjects: Immune-mediated inflammatory disorders (IMIDs); Disease-modifying antirheumatic drugs (DMARDs); Immunosuppressants

• Source: BMC Oral Health, Vol 25, Iss 1, Pp 1-27 (2025)

تفاصيل العنوان

Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: Results from the ARTIS programme

• Authors : Frisell, Thomas; Bower, Hannah; Morin, Matilda ...

Subjects: Medical and Health Sciences; Clinical Medicine; Medicin och hälsovetenskap

• Source: Annals of the Rheumatic Diseases. 82(5):601-610

تفاصيل العنوان

Cancer risks with JAKi and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis or psoriatic arthritis: a national real-world cohort study

• Authors : Huss, V; Bower, H; Hellgren, K

Subjects: Medicin och hälsovetenskap

• Source: Annals of the rheumatic diseases. 82(7):911-919

تفاصيل العنوان

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

• Authors : Smolen, JS; Landewe, RBM; Bergstra, SA

Subjects: Medicin och hälsovetenskap

• Source: Annals of the rheumatic diseases. 82(1):3-18

تفاصيل العنوان

Predictors at diagnosis for start of biologic disease-modifying antirheumatic drugs in patients with early rheumatoid arthritis: a cohort study

• Authors : Hameed, Mohaned; Exarchou, Sofia; Eberhard, Anna ...

Subjects: Medical and Health Sciences; Clinical Medicine; Medicin och hälsovetenskap

• Source: BMJ Open. 14(2)

تفاصيل العنوان

Rituximab, Apremilast, and Upadacitinib as Selected Biosimilar and Targeted Synthetic Disease-Modifying Antirheumatic Drugs with Diverse Mechanisms of Action: Their Current Use in Slowing Down the Progression of Disease.

• Authors : Kawczak, Piotr¹ (AUTHOR) ; Feszak, Igor Jarosław² (AUTHOR); Bączek, Tomasz^1,3 (AUTHOR)

• Source: Journal of Clinical Medicine. Apr2025, Vol. 14 Issue 8, p2605. 22p.

تفاصيل العنوان

Body composition and skeletal muscles status in patients with rheumatoid arthritis during treatment with biologic disease-modifying antirheumatic drugs

• Authors : O. V. Dobrovolskaya; M. V. Kozyreva; N. V. Demin

Subjects: rheumatoid arthritis; body composition; biologic disease-modifying antirheumatic drugs

• Source: Современная ревматология, Vol 19, Iss 1, Pp 29-34 (2025)

تفاصيل العنوان